TELO
Telomir Pharmaceuticals, Inc. Common Stock
1W: +0.0%
1M: +16.8%
3M: -2.2%
YTD: -1.5%
1Y: -69.7%
$1.32
+0.00 (+0.00%)
After Hours: $1.24 (-0.08, -6.06%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$45.4M
52W Range1.05-4.805
Volume65,363
Avg Volume142,283
Beta-0.65
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOErez Aminov
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2019-04-09
Websitetelomirpharma.com
855 N Wolfe Street
Baltimore, FL 21205
US
Baltimore, FL 21205
US
(737)-289-0835
About Telomir Pharmaceuticals, Inc. Common Stock
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.
Latest News
Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models
Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging
Telomir Pharmaceuticals (TELO) to Release Quarterly Earnings on Tuesday
Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models
Telomir Pharmaceuticals (NASDAQ:TELO) Shares Down 8.9% – Here’s What Happened
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| MIRA PHARMACEUTICALS | 0 | — | 2025-09-29 | |
| Aminov Erez | A-Award | 2,000,000 | $2.10 | 2025-05-28 |
| Aminov Erez | A-Award | 400,000 | — | 2025-05-28 |
| Weichselbaum Alan | 50,000 | $2.75 | 2025-05-15 | |
| Aminov Erez | 0 | — | 2024-12-31 |